Is this your podcast?
Sign up to track ranks and reviews from Spotify, Apple Podcasts and more
Erin Harris
Cell & Gene: The Podcast
Cell & Gene, the most valuable online resource for delivering in-depth content from authoritative authors and sources to professionals in the CGT sector, introduces Cell & Gene: The Podcast. In each episode, Cell & Gene Chief Editor, Erin Harris, will talk to industry and academic leaders about their current initiatives and how they are moving the sector forward.
Listen now
Ratings & Reviews
4.9 stars from 36 ratings
Top Notch Podcast
I’ve learned a great deal listening to this podcast. Erin Harris does a fantastic job of keeping the topics current and the guests she has on are all leaders in the industry.
buck025 via Apple Podcasts · United States of America · 03/02/22
If you’re interested in what the leaders of the cell therapy and gene therapy market think, this is well worth a subscribe.
Derek VS via Apple Podcasts · United States of America · 03/02/22
Required Listening
The cell and gene space is growing and developing quickly. The Cell and Gene Podcast is the best way to keep up with this exciting and quickly developing segment of the pharma industry.
MoodyPooty via Apple Podcasts · United States of America · 03/01/22
Recent Episodes
In 2021 on Episode 13, Vor Bio’s President and CEO, Dr. Robert Ang shared data about the company’s lead engineered hematopoietic cell (eHSC) product candidate. Dr. Ang is back to talk to Cell & Gene: The Podcast Host, Erin Harris, about how Vor has treated 8 patients demonstrating clinical...
Published 04/11/24
Published 04/11/24
Orca Bio's CMO, Dr. Scott McClellan, joins Erin Harris on this episode of Cell & Gene: The Podcast to discuss how and why toxicities continue to stymie allogeneic cell therapies. They cover Orca Bio's plan to potentially lowering the risk of GvHD as well as Orca-T, the investigational...
Published 03/28/24
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »